John V. Oyler is the Co-Founder, Chairman, and CEO of BeiGene, a global oncology company dedicated to providing high-quality therapies worldwide. An alumnus of MIT and Stanford, he combines advanced technical education with leadership in biotechnology. Under his guidance, BeiGene focuses on expanding access to cancer treatments globally, reflecting his expertise in oncology and pharmaceutical innovation.

‌